Shetty Reshma P.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Jan 24, 2023
- Accession no.
- 0001127602-23-002137
- Filed
- Jan 24, 2023
- Trade date
- Jan 20-23, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.01M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shetty Reshma P.CIK 0001873523 | Director, Officer (See remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 | Class A Common Stock | SSaleDisposed | −152,205 | $1.67 | −$254,182.35 | 15,990,662 | Direct | |
| Jan 20, 2023 | Class A Common Stock | SSaleDisposed | −152,205 | $1.67 | −$254,182.35 | 15,990,652 | Indirect | |
| Jan 23, 2023 | Class A Common Stock | SSaleDisposed | −143,807 | $1.75 | −$251,662.25 | 15,846,855 | Direct | |
| Jan 23, 2023 | Class A Common Stock | SSaleDisposed | −143,808 | $1.75 | −$251,664 | 15,846,844 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
President, COO & Founder